2d
Mens Fitness on MSNFamous Biohacker Takes Ketamine and Tracks His Brain. The Results Surprised Even Him.Monitored for 10 days leading up to the ketamine experiment, Johnson's brain activity followed fixed, predictable patterns.
Magnesium threonate supports brain health, enhances memory, reduces migraines, and may help prevent cognitive decline.
Hosted on MSN29d
How to Increase GABA and Balance Your GlutamateIncreasing gamma-aminobutyric acid (GABA) and balancing glutamate, brain chemicals called neurotransmitters, may help alleviate symptoms of fibromyalgia (FMS) and chronic fatigue syndrome (ME/CFS).
Now, new research from the Warren Center for Neuroscience Drug Discovery (WCNDD) offers hope. Scientists have identified a ...
Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers from Japan have now discovered that opioid delta-receptor ...
Some nerve cells in the brain involved in mood use a chemical called glutamate to communicate with each other. The nerve cells need glutamate receptors – think of them like catcher’s mitts for ...
The scans revealed that the difficult-task group had higher levels of the neurotransmitter glutamate in that area of the brain at the end of the day when compared to the easy-task group. That result ...
A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with ...
Glutamate is what many of the neurons in your brain use to communicate with each other, and without it, well, your brain would essentially shut down like a city grid without power. Now ...
We have investigated the role of mitochondrial calcium buffering in excitotoxic cell death. Glutamate acts at NMDA receptors in cultured rat forebrain neurons to increase the intracellular free ...
Mariella is an assistant editor at The Scientist. She has a background in neuroscience, and her work has appeared in Drug Discovery News and Massive Science. View Full Profile. Learn about our ...
The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results